TB Centre LSHTM
@tb-lshtm.bsky.social
One of the largest networks of TB experts in the world, harnessing diverse disciplinary expertise to end TB globally
Calling all emerging #researchers doing pioneering work to reduce the disease burden of #TB & #HIV in #Africa #Nominations for 2026 Stephen Lawn Research Leadership Prize now open! @joylawn.bsky.social @thelancetinfdis.bsky.social @theunion.org @mrcunitgambia.bsky.social @mrcunitgambia.bsky.social
Stephen Lawn TB-HIV Research Leadership Prize 2026 | LSHTM
Stephen Lawn TB-HIV Research Leadership Prize 2026 | LSHTM
tinyurl.com
Antimicrobial resistance is one of today's biggest global health challenges 🦠 Join our online short course (28 September–2 October 2026) to learn from global experts & gain practical knowledge to help tackle #AMR across policy, research & practice. Apply now 👉 www.lshtm.ac.uk/study/course...
Poverty is a major driver of TB.Conditional cash transfers combined with counselling improve pre-treatment loss to follow-up.In this economic analysis our modelling projections show that this intervention is cost-effective and can reduce incidence and mortality. www.sciencedirect.com/science/arti...
Cost-effectiveness of conditional cash transfers with pre- and post-test tuberculosis counselling in South Africa: a modelling analysis
Tuberculosis (TB) disproportionately affects low-income populations due to socioeconomic barriers. Conditional cash transfers (CCTs) are promising str…
sciencedirect.com
New publication now out in @lancetgh.bsky.social! New #TB #vaccines are being trialled in older adolescents and adults, and we comment on the advantages and challenges of including younger adolescents who have historically been excluded. www.thelancet.com/journals/lan...
Inclusion of young adolescents in policy development for new tuberculosis vaccines
The infant tuberculosis vaccine, BCG, prevents severe tuberculosis disease, but protection is rarely durable beyond childhood. New tuberculosis vaccines are being developed for the prevention of infec...
thelancet.com
Join us Wednesday 17 June⏰ 17:15 "Rebalancing TB care: Improving outcomes for the 96% with drug sensitive TB" with Dr Salome Charalambous www.lshtm.ac.uk/newsevents/e...
Rebalancing TB care: Improving outcomes for the 96% with drug sensitive TB with
Each year, an estimated 10.7 million people develop tuberculosis (TB), with 96% affected by drug-sensitive TB (DS TB) — a form of the disease that continues to have devastating consequences for
lshtm.ac.uk
⚕️ A recent @tb-lshtm.bsky.social modelling study found that 134 million people were living with a recent Mycobacterium tuberculosis infection Centre member @aschwalbc.bsky.social wrote about these findings & their implications Read more 🔽 www.lshtm.ac.uk/research/cen...
Out now! Our preprint reviewing effects of extreme weather events on TB. papers.ssrn.com/sol3/papers.... @mjsaunder.bsky.social with Lauren Linde & Leo Martinez @bostonu.bsky.social & many others @tb-lshtm.bsky.social @lshtm-tbmod.bsky.social @lshtm-planet.bsky.social
Today, we kick off a weeklong Foundations of Laboratory Leadership & Management training for 20 staff from our #Fajara, #Keneba & #Basse field stations. The training will provide participants with skills for managing laboratory systems & enhancing leadership in #GlobalHealth research programs.
The Paul Farmer Lectureship and Award for Global Health Equity at @mcgill.ca @mcgillspgh.bsky.social 2026 Call for Nominations www.mcgill.ca/spgh/about-u...
@tb-lshtm.bsky.social Seminar, free & open to all 📆 12 May ⏰ 12.45 BST Developing directed acrylic graphs to understand TB care engagement www.lshtm.ac.uk/newsevents/e...
Developing directed acrylic graphs to understand TB care engagement | LSHTM
Directed acyclic graphs (DAGs) are a key epidemiological tool currently underutilised in TB studies, which often involve complex social factors. In describing her team’s recent DAG development
lshtm.ac.uk
🗞️ In two new publications, members of @tb-lshtm.bsky.social explore the gaps that people living with #TB can fall into at the beginning or end of the care pathway, including post-TB #PublicHealth Read more 🔽 www.lshtm.ac.uk/research/cen...
📈 Want to learn about infectious disease modelling? Our @lshtm.bsky.social @ukhsa.bsky.social course teaches the basics for modelling #InfectiousDisease outbreaks and control programmes in #PublicHealth Runs from 15-27 June 2026 with online & in-person spots Join 🔽 www.lshtm.ac.uk/study/course...
#Post-tuberculosis lung disease: no ICD code, no problem? - The Lancet Respiratory Medicine www.thelancet.com/journals/lan...
#Post-tuberculosis lung disease: no ICD code, no problem?
Zintle was aged 23 years when she presented for the first time to our clinic in South Africa. Her oxygen saturation was 59% on room air, and for months she had been too short of breath to leave her ho...
thelancet.com
New study led by @alexandra-richards.bsky.social. Reducing men’s TB risk and improving treatment access could have big impacts on #TB incidence and deaths for men, women, and children. www.nature.com/articles/s43... @kchorton.bsky.social @uofgshw.bsky.social @lightontb.bsky.social
The LIGHT Consortium @lightontb.bsky.social · 4mo agoWhat if targeting TB in men could benefit entire populations? This new modelling study from @alexandra-richards.bsky.social suggests exactly that 👇 ✔️ More treatment coverage ✔️ Address social & structural risks 👉 Big reductions in TB incidence & mortality 🔗 www.nature.com/articles/s43...
Today! Don't miss this! tinyurl.com/47w5nmtp
New vaccines to dramatically interrupt the TB epidemic with Professor Willem
This annual lecture is organised in honour of the life and work of Stephen Lawn. Steve was Professor of Infectious Diseases and Tropical Medicine at the London School of Hygiene & Tropical Medicine
tinyurl.com
TB Centre LSHTM@tb-lshtm.bsky.social · 4mo agoTomorrow! If you're not lucky enough to be in Cape Town in person, @tb-lshtm.bsky.social is hosting a watch party in London or join remotely tinyurl.com/47w5nmtp ⏰ 15.30 BST @theunion.org @thelancet.com @joylawn.bsky.social @sedonasweeney.bsky.social @hr-stagg.bsky.social @lshtm-tbmod.bsky.social
PLEASE NOTE: The correct time to join is 15.30 BST not 14.30 GMT as advertisted on the flyer.
TB Centre LSHTM@tb-lshtm.bsky.social · 4mo agoTomorrow! If you're not lucky enough to be in Cape Town in person, @tb-lshtm.bsky.social is hosting a watch party in London or join remotely tinyurl.com/47w5nmtp ⏰ 15.30 BST @theunion.org @thelancet.com @joylawn.bsky.social @sedonasweeney.bsky.social @hr-stagg.bsky.social @lshtm-tbmod.bsky.social
Tomorrow! If you're not lucky enough to be in Cape Town in person, @tb-lshtm.bsky.social is hosting a watch party in London or join remotely tinyurl.com/47w5nmtp ⏰ 15.30 BST @theunion.org @thelancet.com @joylawn.bsky.social @sedonasweeney.bsky.social @hr-stagg.bsky.social @lshtm-tbmod.bsky.social
Tuberculosis in Europe: progress - but not fast enough. While rates have declined over time, current trends show we are not on track to meet the 2030 global tuberculosis targets. #TB #Tuberculosis #IDsky #EpiSky #MedSky
🌏 Ahead of World TB Day, new research @lshtm.bsky.social highlights how TB survivors still face worse outcomes up to 14 years after diagnosis and treatment Findings make compelling case for long-term follow-ups after TB treatments to #EndTB Read more 🔽 www.lshtm.ac.uk/research/cen...
Claire Calderwood: integrated health screening for tuberculosis - The Lancet www.thelancet.com/journals/lan...
Claire Calderwood: integrated health screening for tuberculosis
“Respiratory medicine is deeply connected to social and structural determinants of health in terms of the diseases that we try to prevent and we treat. I think that connection to people's lives and so...
thelancet.com
🆕 A Profile captures the work and advocacy of Claire Calderwood, winner of the 2025 Stephen Lawn TB–HIV Research Leadership Prize: spkl.io/63325AL4x3 #WorldTBDay @joylawn.bsky.social @tb-lshtm.bsky.social
This #WorldTBday is a honour to be in Blantyre, Malawi, where we kicked off recruitment into the @wellcometrust.bsky.social funded ZAMSA-TB study. The team are developing new epidemiological methods to measure future vaccine effectiveness in the community.
On World TB Day... #IDSky #TBSky @thelancetinfdis.bsky.social www.thelancet.com/journals/lan...
Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap
In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed t...
thelancet.com
Joint @tb-lshtm.bsky.social & @ucltb.bsky.social World TB Day Symposium 2026 has begun A full day of presentation of latest research findings, panel discussions, and engagement with people with lived experiences. "Yes, We Can End TB!" @mrcunitgambia.bsky.social MRC/UVRI & LSHTM Uganda Research Unit
Our World TB Day Symposium 2026 is just one week away! Join in person or online, 24 March for the annual UCL/LSHTM symposium, free and open to all. Programme details and registration link: www.lshtm.ac.uk/newsevents/e...
📣 #PhD thesis now live in Research Online! Heterogeneity in Mycobacterium tuberculosis immunoreactivity in urban Malawi: revisiting surveillance needs for tuberculosis elimination/ Rickman, H M doi.org/10.17037/PUB... #tuberculosis #Malawi
🗞️ Recent study with @lshtm-tbmod.bsky.social modelled the potential impact of funding cuts to TB #PublicHealth initiatives from international donors Already implemented USAID cuts could cost $7.5 billion (USD) for healthcare systems & people living with TB Read 🔽 www.lshtm.ac.uk/research/cen...
@tb-lshtm.bsky.social amazing #StudentAmbassadors 2025-26 highlight why everyone interested in TB should join us for these two amazing events marking #WTBD2026 PS: they are both free and open to all! @ucltb.bsky.social @mrcunitgambia.bsky.social @mrcctu.bsky.social @lshtm-tbmod.bsky.social
